Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-07 Purchase(A) |
2022-09-13 5:57 pm |
Evolus Inc. | EOLS | HAYMAN ROBERT Director |
5,000 | $10.05 | $50,250 | 39,881 (Direct) |
View |
| 2022-09-08 Sale |
2022-09-12 5:45 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
36,000 | $10.47 | $376,890 | 7,401,652 (Direct) |
View |
| 2022-09-07 Purchase |
2022-09-09 5:01 pm |
Evolus Inc. | EOLS | HAYMAN ROBERT Director |
4,967 | $10.05 | $49,918 | 39,848 (Direct) |
View |
| 2022-09-06 Purchase |
2022-09-08 09:29 am |
Evolus Inc. | EOLS | BLANK SIMONE Director |
20,000 | $9.2422 | $184,844 | 422,458 (Indirect Direct) |
View |
| 2022-09-06 Purchase |
2022-09-06 8:03 pm |
Evolus Inc. | EOLS | FARRELL PETER C Director |
10,000 | $9.1048 | $91,048 | 44,881 (Indirect Direct) |
View |
| 2022-08-01 Sale |
2022-08-03 4:08 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
26,000 | $13.28 | $345,361 | 7,437,652 (Direct) |
View |
| 2022-05-16 Sale |
2022-05-18 8:21 pm |
Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks |
55,321 | $13.64 | $754,307 | 491,961 (Direct) |
View |
| 2022-05-17 Sale |
2022-05-18 8:21 pm |
Evolus Inc. | EOLS | SILVERNAIL LAUREN P See Remarks |
68,204 | $12.78 | $871,380 | 141,571 (Direct) |
View |
| 2022-05-13 Sale |
2022-05-17 6:49 pm |
Evolus Inc. | EOLS | GILL DAVID N Director |
10,313 | $13.35 | $137,664 | 29,568 (Direct) |
View |
| 2022-03-28 Sale |
2022-03-30 7:02 pm |
Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks |
6,104 | $11.62 | $70,928 | 547,282 (Direct) |
View |
| 2022-03-08 Sale |
2022-03-10 7:24 pm |
Evolus Inc. | EOLS | Muilenburg Crystal Chief Marketing Officer |
6,495 | $9.7254 | $63,166 | 134,248 (Direct) |
View |
| 2022-03-08 Sale |
2022-03-10 7:24 pm |
Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks |
37,972 | $9.7254 | $369,293 | 553,386 (Direct) |
View |
| 2022-03-08 Sale |
2022-03-10 7:23 pm |
Evolus Inc. | EOLS | Avelar Rui See Remarks |
10,192 | $9.7254 | $99,121 | 253,189 (Direct) |
View |
| 2022-03-08 Sale |
2022-03-10 7:23 pm |
Evolus Inc. | EOLS | SILVERNAIL LAUREN P See Remarks |
10,192 | $9.7254 | $99,121 | 209,775 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-07 5:37 pm |
Evolus Inc. | EOLS | Alphaeon 1 LLC 10% Owner |
2,597,475 | $9.5 | $24,676,013 | 6,064,871 (Direct) |
View |
| 2021-08-27 Purchase |
2021-08-31 4:19 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
51,000 | $10.93 | $557,568 | 7,463,652 (Direct) |
View |
| 2021-08-25 Purchase |
2021-08-27 4:21 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
110,000 | $11.06 | $1,216,791 | 7,412,652 (Direct) |
View |
| 2021-08-23 Sale |
2021-08-25 6:37 pm |
Evolus Inc. | EOLS | Malik Vikram Director |
26,077 | $11 | $286,722 | 1,143,701 (Indirect) |
View |
| 2021-08-23 Purchase |
2021-08-25 4:21 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
142,000 | $11.1 | $1,576,808 | 7,302,652 (Direct) |
View |
| 2021-08-19 Purchase |
2021-08-23 4:26 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
103,000 | $10.53 | $1,084,808 | 7,160,652 (Direct) |
View |
| 2021-08-19 Sale |
2021-08-20 8:19 pm |
Evolus Inc. | EOLS | Malik Vikram Director |
61,840 | $10.59 | $654,871 | 1,169,778 (Indirect) |
View |
| 2021-08-17 Sale |
2021-08-19 7:01 pm |
Evolus Inc. | EOLS | Malik Vikram Director |
67,083 | $10.2 | $684,561 | 1,231,618 (Indirect) |
View |
| 2021-08-17 Purchase |
2021-08-19 4:15 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
115,000 | $10.63 | $1,222,137 | 7,057,652 (Direct) |
View |
| 2021-08-13 Sale |
2021-08-17 8:24 pm |
Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks |
70,445 | $11.13 | $783,810 | 377,072 (Direct) |
View |
| 2021-08-13 Purchase |
2021-08-17 4:10 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
114,714 | $11.18 | $1,282,751 | 6,942,652 (Direct) |
View |
| 2021-08-11 Purchase |
2021-08-13 4:33 pm |
Evolus Inc. | EOLS | Medytox Inc. 10% Owner |
65,286 | $10.87 | $709,452 | 6,827,938 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-05 Option Award |
2022-09-06 5:08 pm |
N/A 2032-09-05 |
Evolus Inc. | EOLS | Beaver Sandra Chief Financial Officer |
205,601 | $0 | 205,601 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 9:03 pm |
N/A 2032-01-25 |
Evolus Inc. | EOLS | MOATAZEDI DAVID See Remarks |
524,845 | $0 | 901,917 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 9:03 pm |
N/A 2032-01-25 |
Evolus Inc. | EOLS | SILVERNAIL LAUREN P See Remarks |
131,211 | $0 | 297,607 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 9:02 pm |
N/A 2032-01-25 |
Evolus Inc. | EOLS | Avelar Rui See Remarks |
131,211 | $0 | 341,021 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 9:02 pm |
N/A 2032-01-25 |
Evolus Inc. | EOLS | Muilenburg Crystal Chief Marketing Officer |
122,464 | $0 | 213,207 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 9:02 pm |
N/A 2032-01-24 |
Evolus Inc. | EOLS | Malik Vikram Director |
38,295 | $0 | 92,019 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 9:01 pm |
N/A 2032-01-24 |
Evolus Inc. | EOLS | Parschauer Karah Herdman Director |
38,295 | $0 | 57,608 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 9:01 pm |
N/A 2032-01-24 |
Evolus Inc. | EOLS | GILL DAVID N Director |
38,295 | $0 | 62,608 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 9:01 pm |
N/A 2032-01-24 |
Evolus Inc. | EOLS | FARRELL PETER C Director |
38,295 | $0 | 57,608 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 9:00 pm |
N/A 2032-01-24 |
Evolus Inc. | EOLS | HAYMAN ROBERT Director |
38,295 | $0 | 57,608 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 9:00 pm |
N/A 2032-01-24 |
Evolus Inc. | EOLS | BLANK SIMONE Director |
38,295 | $0 | 57,608 (Direct) |
View |
| 2022-01-05 Option Award |
2022-01-07 5:23 pm |
N/A N/A |
Evolus Inc. | EOLS | Stewart Brady Director |
36,508 | $0 | 36,508 (Direct) |
View |